Provision of Genomic Medicine Software and Teaching for the RCSI ‘Enabling Future Pharma, Beyond the Pill’ Project in Accordance with Programme Requirements
‘Enabling Future Pharma – Beyond the Pill’, is developing a suite of innovative and agile programmes aimed to create a skilled talent pool focused on emerging and future pharma technologies, addressing skills gaps in industry and enabling future growth. Specifically, RCSI and its partners are developing a MSc in Precision Medicine and Innovation and a BSc in advanced therapeutic technologies. These two programmes will be delivered using cutting edge educational technology to maximise flexible delivery. Learning outcomes will focus on technological knowledge and skills, in combination with transversal skills.
In order to develop and implement these programmes, RCSI requires access to software that enables students in the diagnostic interpretation of whole genome and exome next-generation sequence data. In addition, we require industry-informed teaching in specific areas related to the clinical application of genomics.
Deadline
The time limit for receipt of tenders was 2021-04-28.
The procurement was published on 2021-03-29.
Object Scope of the procurement
Title:
“Provision of Genomic Medicine Software and Teaching for the RCSI ‘Enabling Future Pharma, Beyond the Pill’ Project in Accordance with Programme...”
Title
Provision of Genomic Medicine Software and Teaching for the RCSI ‘Enabling Future Pharma, Beyond the Pill’ Project in Accordance with Programme Requirements
RCSI_GenomicMedicine
Show more
Products/services: Software package and information systems📦
Short description:
“‘Enabling Future Pharma – Beyond the Pill’, is developing a suite of innovative and agile programmes aimed to create a skilled talent pool focused on...”
Short description
‘Enabling Future Pharma – Beyond the Pill’, is developing a suite of innovative and agile programmes aimed to create a skilled talent pool focused on emerging and future pharma technologies, addressing skills gaps in industry and enabling future growth. Specifically, RCSI and its partners are developing a MSc in Precision Medicine and Innovation and a BSc in advanced therapeutic technologies. These two programmes will be delivered using cutting edge educational technology to maximise flexible delivery. Learning outcomes will focus on technological knowledge and skills, in combination with transversal skills.
In order to develop and implement these programmes, RCSI requires access to software that enables students in the diagnostic interpretation of whole genome and exome next-generation sequence data. In addition, we require industry-informed teaching in specific areas related to the clinical application of genomics.
Show more
Estimated value excluding VAT: EUR 500 000 💰
‘Enabling Future Pharma – Beyond the Pill’, is developing a suite of innovative and agile programmes aimed to create a skilled talent pool focused on emerging and future pharma technologies, addressing skills gaps in industry and enabling future growth. Specifically, RCSI and its partners are developing a MSc in Precision Medicine and Innovation and a BSc in advanced therapeutic technologies. These two programmes will be delivered using cutting edge educational technology to maximise flexible delivery. Learning outcomes will focus on technological knowledge and skills, in combination with transversal skills.
In order to develop and implement these programmes, RCSI requires access to software that enables students in the diagnostic interpretation of whole genome and exome next-generation sequence data. In addition, we require industry-informed teaching in specific areas related to the clinical application of genomics.
Show more Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
Scope of the procurement
Estimated total value excluding VAT: EUR 500 000 💰
Duration of the contract, framework agreement or dynamic purchasing system
The time frame below is expressed in number of months.
Description
Duration: 48
Legal, economic, financial and technical information Economic and financial standing
Selection criteria as stated in the procurement documents
Technical and professional ability
Selection criteria as stated in the procurement documents
Procedure Type of procedure
Open procedure
Administrative information
Time limit for receipt of tenders or requests to participate: 2021-04-28
12:00 📅
Languages in which tenders or requests to participate may be submitted: English 🗣️
Tender must be valid until: 2021-07-28 📅
Conditions for opening of tenders: 2021-04-28
12:00 📅
Complementary information Review body
Name: Rcsi
Postal town: Dublin
Country: Ireland 🇮🇪
Source: OJS 2021/S 065-163340 (2021-03-29)